Literature DB >> 22335030

Expression of IGF-1R, VEGF-C and D2-40 and their correlation with lymph node metastasis in endometrial adenocarcinoma.

H Pengchong1, H Tao.   

Abstract

Insulin-like growth factor-1 receptor (IGF-1R) regulates carcinogenesis and tumor development and is expressed in normal endometrium. Vascular endothelial growth factor C (VEGF-C) promotes lymph node metastasis. We investigated IGF-1R, VEGF-C and D2-40 in endometrial adenocarcinoma and the association between IGF-1R and lymphatic metastasis, using an immunohistochemical S-P method with 40 cases of endometrial adenocarcinoma and 14 of normal endometrium. IGF-1R expression differed significantly between normal endometrium and adenocarcinoma; it was associated with histological grade but not surgical stage. IGF-1R overexpression was associated with metastasis, but expression was not. VEGF-C expression was greater in normal endometrium than in adenocarcinoma and was associated with metastasis but not with surgical stage or histological grade. IGF-IR and VEGF-C expression were correlated in endometrial adenocarcinoma, and lymphatic vessel density was closely related to both. Abnormal IGF-IR and VEGF-C expression may be important in lymph node metastasis of endometrial adenocarcinoma and might be used to evaluate the prognosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22335030

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  12 in total

Review 1.  The endometrial lymphatic vasculature: function and dysfunction.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

2.  Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.

Authors:  Shuming He; Shumei Zeng; Zhi-Wei Zhou; Zhi-Xu He; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-02-18       Impact factor: 4.162

Review 3.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

4.  Expression of hypoxic signaling markers in head and neck squamous cell carcinoma and its clinical significance.

Authors:  Hyo Geun Choi; Jin-Soo Kim; Ki Hwan Kim; Kwang Hyun Kim; Myung-Whun Sung; Ji-Young Choe; Ji Eun Kim; Young Ho Jung
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-14       Impact factor: 2.503

5.  microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.

Authors:  Ying Song; Yue Zhao; Xiangfu Ding; Xiaodong Wang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

6.  MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.

Authors:  Ying Ye; Juhua Zhuang; Guangdong Wang; Saifei He; Suiliang Zhang; Guoyu Wang; Jing Ni; Jiening Wang; Wei Xia
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.751

Review 7.  The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches.

Authors:  Ilan Bruchim; Rive Sarfstein; Haim Werner
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-19       Impact factor: 5.555

8.  microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.

Authors:  Lili Lv; Xiaodong Wang; Tonghui Ma
Journal:  Cancer Manag Res       Date:  2019-03-29       Impact factor: 3.989

9.  Regulation of insulin-like growth factor signaling by metformin in endometrial cancer cells.

Authors:  Ya Xie; Jing-Lu Wang; Mei Ji; Zhong-Fu Yuan; Zheng Peng; Yi Zhang; Jian-Guo Wen; Hui-Rong Shi
Journal:  Oncol Lett       Date:  2014-08-20       Impact factor: 2.967

10.  Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?

Authors:  Anna Markowska; Monika Pawałowska; Violetta Filas; Konstanty Korski; Marian Gryboś; Stefan Sajdak; Anita Olejek; Wiesława Bednarek; Beata Spiewankiewicz; Jolanta Lubin; Janina Markowska
Journal:  Diabetol Metab Syndr       Date:  2013-12-05       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.